EUVIMEDEUVIMED entdecken
Multizentrische Studie

Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator

Mehmet K Aktaş, Arwa Younis, Shireen Saxena, Alexander Diamond, Amole Ojo, Valentina Kutyifa, Hillel Steiner, Jonathan S Steinberg, Wojciech Zareba, Scott McNitt, Bronislava Polonsky, Spencer Z Rosero und 2 weitere

JACC: Clinical Electrophysiology · 2023-07 · 9 (7) · 979-988

DOI: 10.1016/j.jacep.2022.11.020 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2023-07. Verfasst von Mehmet K Aktaş und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA. Electronic address: mehmet_aktas@urmc.rochester.edu. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Tachycardia, Ventricular, Cardiomyopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The benefit of implantable cardioverter-defibrillators (ICDs) in elderly patients is controversial. OBJECTIVES: The aims of this study were to evaluate the risk for ventricular tachyarrhythmia (VTA) and ICD shocks by age groups and to assess the competing risk for VTA and death without prior VTA. METHODS: The study included 5,170 primary prevention ICD recipients enrolled in 5 landmark ICD trials (MADIT [Multicenter Automatic Defibrillator Implantation Trial] II, MADIT-Risk, MADIT-CRT [MADIT Cardiac Resynchronization Therapy], MADIT-RIT [MADIT Reduce Inappropriate Therapy], and RAID [Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillator]). Fine and Gray regression analysis was used to evaluate the risk for fast VTA (ventricular tachycardia ≥200 beats/min or ventricular fibrillation) vs death without prior fast VTA in 3 prespecified age groups:

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableTachycardia, VentricularCardiomyopathiesHumansMaleAgedVentricular FibrillationElectric Countershock

Stichwörter der Autor:innen

ICD shockagemortalityventricular fibrillationventricular tachycardia

Autor:innen und Institutionen

  • Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA. Electronic address: mehmet_aktas@urmc.rochester.edu.
  • Clinical Cardiovascular Research Center, University of Rochester, Rochester, New York, USA.
  • The Edith Wolfson Medical Center, Holon, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Aktaş, M. K., Younis, A., Saxena, S., Diamond, A., Ojo, A., Kutyifa, V., Steiner, H., Steinberg, J. S., Zareba, W., McNitt, S., Polonsky, B., Rosero, S. Z., Huang, D. T., & Goldenberg, I. (2023). Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator. JACC: Clinical Electrophysiology, 9(7), 979-988. https://doi.org/10.1016/j.jacep.2022.11.020

Vancouver

Aktaş MK, Younis A, Saxena S, Diamond A, Ojo A, Kutyifa V, et al. Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator. JACC: Clinical Electrophysiology. 2023;9(7):979-988. doi:10.1016/j.jacep.2022.11.020

BibTeX
@article{Akta2023,
  author = {Aktaş, Mehmet K and Younis, Arwa and Saxena, Shireen and Diamond, Alexander and Ojo, Amole and Kutyifa, Valentina and Steiner, Hillel and Steinberg, Jonathan S and Zareba, Wojciech and McNitt, Scott and Polonsky, Bronislava and Rosero, Spencer Z and Huang, David T and Goldenberg, Ilan},
  title = {Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator},
  journal = {JACC: Clinical Electrophysiology},
  year = {2023},
  volume = {9},
  number = {7},
  pages = {979--988},
  doi = {10.1016/j.jacep.2022.11.020}
}
Kostenlos starten →